Dr Rob De Rose
Research Fellow
Department of Infectious Diseases
115 Scholarly works
13 Projects
HIGHLIGHTS
2025
Journal article
Amplifying the Immune Activity of Metal Ions through Metal-Phenolic Complexation
DOI: 10.1021/acsnano.5c018422025
Journal article
Trafficking Glycogen Nanoparticles through Lymph Node Tissues for the Delivery of Small and Large Bioactive Molecules
DOI: 10.1021/acsnano.5c131342024
Journal article
mRNA delivery enabled by metal–organic nanoparticles
DOI: 10.1038/s41467-024-53969-w2024
Journal article
A Metal–Phenolic Network-Enabled Nanoadjuvant to Modulate Immune Responses
DOI: 10.1002/smll.2024017762024
Research contracts (non-grants)
In Vivo Analysis of Lung Targetting LNP
2022
Research grants (other domestic)
mRNA-based Antiviral Therapeutics for SARS-CoV-2 Using Cas13
2022
Research Grant
mRNA-based Antiviral Therapeutics for SARS-CoV-2 Using Cas13
RECENT SCHOLARLY WORKS
2024
Journal article
Metal–Phenolic‐Mediated Assembly of Functional Small Molecules into Nanoparticles: Assembly and Bioapplications
DOI: 10.1002/ange.2023195832024
Journal article
Metal–Phenolic-Mediated Assembly of Functional Small Molecules into Nanoparticles: Assembly and Bioapplications
DOI: 10.1002/anie.2023195832023
Journal article
Supramolecular Polyphenol-DNA Microparticles for In Vivo Adjuvant and Antigen Co-Delivery and Immune Stimulation
DOI: 10.1002/anie.2022149352023
Journal article
Supramolecular Polyphenol‐DNA Microparticles for In Vivo Adjuvant and Antigen Co‐Delivery and Immune Stimulation
DOI: 10.1002/ange.2022149352023
Journal article
Poly(ethylene glycol) Cross-Linked Antibody Nanoparticles for Tunable Biointeractions
DOI: 10.1021/acs.chemmater.3c003232022
Journal article
Subcutaneous delivery of a dendrimer-BH3 mimetic improves lymphatic uptake and survival in lymphoma
DOI: 10.1016/j.jconrel.2022.05.041
RECENT PROJECTS
2025
Research grants (other domestic)
Developing CRISPR Cas13 Antiviral Therapeutics for Respiratory Pathogens of Pandemic Potential
2022
Internal Research Grant
mRNA-based Antiviral Therapeutics for SARS-CoV-2 Using Cas13